Conexeu Sciences (CNXU)
Develops temperature-responsive collagen scaffolds for wound care and tissue restoration.
$5.54
Pre-market−0.08 (−1.42%)
At close$5.62(−4.26%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Insiders4 holders · as of Aug 18, 2026 | 38.98% | 10.43M shares | |
| Strategic holders3 holders · as of Aug 14, 2026 | 19.28% | 5.16M shares | |
| Otherremainder | 41.74% | 11.17M shares |
26.76M company shares as of Aug 21, 2026 · holders as of their latest filing
Institutions13F
No 13F holders on record.
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Purcell Lynn Sebastian | 12.30% | 3.36M | 13G | Aug 14, 2026 ↗ |
| Wright Michael G. | 12.10% | 3.28M | 13G | Jul 28, 2026 ↗ |
| David Bogart | 8.10% | 2.29M | 13G | Aug 18, 2026 ↗ |
| OnePointTwo Capital Ventures LLC | 6.80% | 1.88M | 13G | Aug 14, 2026 ↗ |
| Paisley Capital Holdings Corp | 6.70% | 1.80M | 13G | Jul 20, 2026 ↗ |
| OnePointTwo Capital Ventures II LLC | 5.50% | 1.48M | 13G | Aug 14, 2026 ↗ |
| Jeffrey Sharpe | 5.40% | 1.50M | 13D | Aug 18, 2026 ↗ |
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.